Surrozen Quote - SRZN

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

11.71

Bid

8.40

Ask

18.17

Volume

40,634

10.50 Day's Range 12.35

5.9999 52 Week Range 18.17

Market Cap

38.055M

Previous Close

10.70

Open

10.54

Last Trade

11.71

Last Trade Time

Financial Volume

US$ 475,969

VWAP

11.7136

Average Volume (3m)

45,189

Shares Outstanding

3,249,798

Dividend Yield

PE Ratio

-0.93

Earnings Per Share (EPS)

-13.24

Revenue

Net Profit

-43.04M

Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS). Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.surrozen.com

Headquarters

Wilmington, Delaware, USA

Founded

Surrozen Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SRZN. The last closing price for Surrozen was US$10.70. Over the last year, Surrozen shares have traded in a share price range of US$ 5.9999 to US$ 18.17.

Surrozen currently has 3,249,798 shares outstanding. The market capitalization of Surrozen is US$34.77 million. Surrozen has a price to earnings ratio (PE ratio) of -0.93.

Surrozen to Present at Upcoming Healthcare Investor Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”...

Surrozen Provides Third Quarter 2024 Financial Results and Business Update

Substantial enrollment progress in Phase 1b trial of SZN-043 in severe alcohol-associated hepatitis patients...

Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”...

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration

Boehringer is advancing the development of SZN-413 to prepare it for potential future clinical testing SZN-413...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Surrozen Provides Second Quarter 2024 Financial Results and Business Update

Enrollment ongoing in SZN-043 Phase 1b trial in patients with Severe Alcoholic Hepatitis Presented...

Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling

Targeted protein degradation (TPD*) technologies have demonstrated the potential to produce novel treatment...

Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan

SZN-043 is a novel biotherapeutic shown to potentiate Wnt signaling and induce proliferation of hepatocytes in...

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis

SZN-043 is a novel hepatocyte-specific R-spondin mimetic bispecific fusion protein targeting ASGR1Anticipate...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.63	5.68592057762	11.08	12.2999	9.5	27740	10.24618286	CS
4	-0.25	-2.09030100334	11.96	13.3399	9.5	31046	11.17620452	CS
12	2.105	21.9156689224	9.605	18.17	8.78	45189	12.02247767	CS
26	4.99	74.255952381	6.72	18.17	6.31	30954	11.29480821	CS
52	1.66	16.5174129353	10.05	18.17	5.9999	21771	11.09442383	CS
156	-30.74	-72.4146054181	42.45	59.5785	4.5	143346	11.75577435	CS
260	-131.54	-91.8254799302	143.25	210	4.5	145644	30.46919998	CS

SRZN - Frequently Asked Questions (FAQ)

What is the current Surrozen share price?

The current share price of Surrozen is US$ 11.71

How many Surrozen shares are in issue?

Surrozen has 3,249,798 shares in issue

What is the market cap of Surrozen?

The market capitalisation of Surrozen is USD 34.77M

What is the 1 year trading range for Surrozen share price?

Surrozen has traded in the range of US$ 5.9999 to US$ 18.17 during the past year

What is the PE ratio of Surrozen?

The price to earnings ratio of Surrozen is -0.93

What is the reporting currency for Surrozen?

Surrozen reports financial results in USD

What is the latest annual profit for Surrozen?

The latest annual profit of Surrozen is USD -43.04M

What is the registered address of Surrozen?

The registered address for Surrozen is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the Surrozen website address?

The website address for Surrozen is www.surrozen.com

Which industry sector does Surrozen operate in?

Surrozen operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
JTAIJet AI Inc	US$ 6.02 (133.33%)	104.48M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	254.39M
WRDWeRide Inc	US$ 31.4877 (83.39%)	21.07M
INLFINLIF Limited	US$ 16.27 (80.58%)	7.68M
MBRXMoleculin Biotech Inc	US$ 2.1201 (66.94%)	136.66M
BLACBellevue Life Sciences Acquisition Corporation	US$ 3.08 (-56.31%)	430.77k
BLACUBellevue Life Sciences Acquisition Corporation	US$ 3.36 (-52.68%)	5.21k
CSAICloudastructure Inc	US$ 19.0001 (-49.58%)	1.03M
NEXNNexxen International Ltd	US$ 10.30 (-49.16%)	164.82k
BSLKBolt Projects Holdings Inc	US$ 0.6626 (-46.13%)	13.4M
CNSPCNS Pharmaceuticals Inc	US$ 0.1415 (31.26%)	489.28M
MGOLMGO Global Inc	US$ 0.7176 (-15.08%)	417.31M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	254.39M
INTCIntel Corporation	US$ 23.60 (-2.20%)	230.26M
NVDANVIDIA Corporation	US$ 138.85 (2.63%)	194.99M